Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2020 2
2021 1
2022 3
2023 4
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions.
Schavgoulidze A, Perrot A, Cazaubiel T, Leleu X, Montes L, Jacquet C, Belhadj K, Brechignac S, Frenzel L, Chalopin T, Rey P, Schiano de Collela JM, Dib M, Caillot D, Macro M, Fontan J, Buisson L, Pavageau L, Roussel M, Manier S, Mohty M, Martinet L, Avet-Loiseau H, Corre J. Schavgoulidze A, et al. Among authors: cazaubiel t. Blood Cancer J. 2023 Oct 26;13(1):160. doi: 10.1038/s41408-023-00933-4. Blood Cancer J. 2023. PMID: 37880285 Free PMC article. No abstract available.
RAS/RAF landscape in monoclonal plasma cell conditions.
Schavgoulidze A, Corre J, Samur MK, Mazzotti C, Pavageau L, Perrot A, Cazaubiel T, Leleu X, Macro M, Belhadj K, Roussel M, Brechignac S, Montes L, Caillot D, Frenzel L, Rey P, Schiano de Colella JM, Chalopin T, Jacquet C, Richez V, Orsini-Piocelle F, Fontan J, Manier S, Martinet L, Sciambi A, Mohty M, Avet-Loiseau H. Schavgoulidze A, et al. Among authors: cazaubiel t. Blood. 2024 Jul 11;144(2):201-205. doi: 10.1182/blood.2023022295. Blood. 2024. PMID: 38643494
Multiple Myeloma: Heterogeneous in Every Way.
Schavgoulidze A, Cazaubiel T, Perrot A, Avet-Loiseau H, Corre J. Schavgoulidze A, et al. Among authors: cazaubiel t. Cancers (Basel). 2021 Mar 13;13(6):1285. doi: 10.3390/cancers13061285. Cancers (Basel). 2021. PMID: 33805803 Free PMC article. Review.
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study.
Jourdes A, Cellerin E, Touzeau C, Harel S, Denis B, Escure G, Faure E, Jamard S, Danion F, Sonntag C, Ader F, Karlin L, Soueges S, Cazelles C, de La Porte des Vaux C, Frenzel L, Lanternier F, Brousse X, Cazaubiel T, Berger P, Collignon A, Blot M, Pieragostini A, Charles M, Chaleteix C, Redor A, Roland V, Cartau T, Macro M, Chalopin T, Vallet N, Perrot A, Martin-Blondel G; G2I and the IFM networks. Jourdes A, et al. Among authors: cazaubiel t. Clin Microbiol Infect. 2024 Jun;30(6):764-771. doi: 10.1016/j.cmi.2024.02.023. Epub 2024 Mar 1. Clin Microbiol Infect. 2024. PMID: 38432433 Free article.
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features.
Cazaubiel T, Leleu X, Perrot A, Manier S, Buisson L, Maheo S, Do Souto Ferreira L, Lannes R, Pavageau L, Hulin C, Marolleau JP, Voillat L, Belhadj K, Divoux M, Slama B, Brechignac S, Macro M, Stoppa AM, Sanhes L, Orsini-Piocelle F, Fontan J, Chretien ML, Demarquette H, Mohty M, Schavgoulidze A, Avet-Loiseau H, Corre J. Cazaubiel T, et al. Blood. 2022 Apr 28;139(17):2666-2672. doi: 10.1182/blood.2021014968. Blood. 2022. PMID: 35171994 Free article.
Risk and Response-Adapted Treatment in Multiple Myeloma.
Cazaubiel T, Mulas O, Montes L, Schavgoulidze A, Avet-Loiseau H, Corre J, Perrot A. Cazaubiel T, et al. Cancers (Basel). 2020 Nov 24;12(12):3497. doi: 10.3390/cancers12123497. Cancers (Basel). 2020. PMID: 33255368 Free PMC article. Review.
Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor.
Schavgoulidze A, Talbot A, Perrot A, Cazaubiel T, Leleu X, Manier S, Buisson L, Mahéo S, Do Souto Ferreira L, Pavageau L, Hulin C, Marolleau JP, Voillat L, Belhadj K, Divoux M, Slama B, Brechignac S, Macro M, Stoppa AM, Sanhes L, Orsini-Piocelle F, Fontan J, Chretien ML, Demarquette H, Mohty M, Avet-Loiseau H, Corre J. Schavgoulidze A, et al. Among authors: cazaubiel t. Blood. 2023 Mar 16;141(11):1308-1315. doi: 10.1182/blood.2022017863. Blood. 2023. PMID: 36375118 Free PMC article.
Empiric antimicrobial therapy for ventilator-associated pneumonia after brain injury.
Roquilly A, Feuillet F, Seguin P, Lasocki S, Cinotti R, Launey Y, Thioliere L, Le Floch R, Mahe PJ, Nesseler N, Cazaubiel T, Rozec B, Lepelletier D, Sebille V, Malledant Y, Asehnoune K; ATLANREA group. Roquilly A, et al. Among authors: cazaubiel t. Eur Respir J. 2016 Apr;47(4):1219-28. doi: 10.1183/13993003.01314-2015. Epub 2016 Jan 7. Eur Respir J. 2016. PMID: 26743488 Free article.
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapse.
Heraudet L, Galtier J, Favre S, Peyraud F, Cazaubiel T, Leroy H, Mottal N, Gros FX, Forcade E, Clément L, Dumas PY, Pigneux A, Leguay T. Heraudet L, et al. Among authors: cazaubiel t. Br J Haematol. 2022 Aug;198(3):523-527. doi: 10.1111/bjh.18218. Epub 2022 May 7. Br J Haematol. 2022. PMID: 35524489
In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations.
Lannes R, Samur M, Perrot A, Mazzotti C, Divoux M, Cazaubiel T, Leleu X, Schavgoulidze A, Chretien ML, Manier S, Adiko D, Orsini-Piocelle F, Lifermann F, Brechignac S, Gastaud L, Bouscary D, Macro M, Cleynen A, Mohty M, Munshi N, Corre J, Avet-Loiseau H. Lannes R, et al. Among authors: cazaubiel t. J Clin Oncol. 2023 Mar 20;41(9):1695-1702. doi: 10.1200/JCO.21.01987. Epub 2022 Nov 7. J Clin Oncol. 2023. PMID: 36343306 Free PMC article.
14 results